Psychiatry · Roseville, CA
NPI
1336247733
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2267 Lava Ridge Ct Ste 125
Roseville, CA, 95661
Phone (916) 771-3717
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
2,876 prescriptions
Company payments, 2025
$847
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Naveen Mishra prescribed most often to Medicare patients was Olanzapine, with 235 prescriptions and refills. In total Naveen Mishra wrote 2,876 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Olanzapine Generic | 235 | 235 | 20 | $6,519 |
| Quetiapine Fumarate Generic | 172 | 174 | 13 | $2,837 |
| Benztropine Mesylate Generic | 124 | 124 | 13 | $1,318 |
| Invega Sustenna Paliperidone Palmitate | 123 | 123 | 17 | $371K |
| Clozapine Generic | 121 | 121 | Under 11 | $11K |
| Escitalopram Oxalate Generic | 114 | 132 | 15 | $1,111 |
| Risperidone Generic | 94 | 95 | Under 11 | $1,727 |
| Trazodone Hcl Generic | 88 | 98 | 13 | $665 |
| Mirtazapine Generic | 83 | 83 | Under 11 | $678 |
| Haloperidol Generic | 77 | 77 | Under 11 | $2,114 |
| Abilify Maintena Aripiprazole | 75 | 75 | Under 11 | $198K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 72 | 72 | Under 11 | $1,311 |
| Divalproex Sodium Er Divalproex Sodium | 69 | 69 | Under 11 | $1,468 |
| Lamotrigine Generic | 66 | 88 | Under 11 | $1,064 |
| Propranolol Hcl Generic | 62 | 68 | Under 11 | $874 |
Brand drugs: - claims; generic drugs: 2,523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Naveen Mishra $847 ($847 in general payments such as food, travel and fees) from 9 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $185.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $185 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $150 |
| Janssen Pharmaceuticals, Inc JNJ | 5 | $123 |
| Abbvie Inc. ABBV | 6 | $116 |
| Alkermes, Inc. ALKS | 4 | $98.36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $62.68 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $54.04 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $39.84 |
| Luye Pharma (USA) Ltd. 2186.HK | 1 | $17.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.